» Articles » PMID: 35696013

The DNA Double-Strand Break Repair in Glioma: Molecular Players and Therapeutic Strategies

Overview
Journal Mol Neurobiol
Date 2022 Jun 13
PMID 35696013
Authors
Affiliations
Soon will be listed here.
Abstract

Gliomas are the most frequent type of tumor in the central nervous system, which exhibit properties that make their treatment difficult, such as cellular infiltration, heterogeneity, and the presence of stem-like cells responsible for tumor recurrence. The response of this type of tumor to chemoradiotherapy is poor, possibly due to a higher repair activity of the genetic material, among other causes. The DNA double-strand breaks are an important type of lesion to the genetic material, which have the potential to trigger processes of cell death or cause gene aberrations that could promote tumorigenesis. This review describes how the different cellular elements regulate the formation of DNA double-strand breaks and their repair in gliomas, discussing the therapeutic potential of the induction of this type of lesion and the suppression of its repair as a control mechanism of brain tumorigenesis.

Citing Articles

Therapy enhancing chromosome instability may be advantageous for gliomas.

Goncharov N, Baklanov I, Gulaia V, Shuliak A, Lanskikh D, Zhmenia V NAR Cancer. 2025; 7(1):zcaf003.

PMID: 39949830 PMC: 11822378. DOI: 10.1093/narcan/zcaf003.


Shikonin Induces Glioma Necroptosis, Stemness Decline, and Impedes (Immuno)Proteasome Activity.

Qin X, Zhang L, Liu J, Lu Y, Zhou F, Jin F Stem Cells Int. 2024; 2024:1348269.

PMID: 39619148 PMC: 11606656. DOI: 10.1155/2024/1348269.


LINC01094: A key long non-coding RNA in the regulation of cancer progression and therapeutic targets.

Yi Q, Zhu G, Zhu W, Wang J, Ouyang X, Yang K Heliyon. 2024; 10(18):e37527.

PMID: 39309878 PMC: 11415682. DOI: 10.1016/j.heliyon.2024.e37527.


Accidental Encounter of Repair Intermediates in Alkylated DNA May Lead to Double-Strand Breaks in Resting Cells.

Fujii S, Fuchs R Int J Mol Sci. 2024; 25(15).

PMID: 39125763 PMC: 11311527. DOI: 10.3390/ijms25158192.


UCHL3 induces radiation resistance and acquisition of mesenchymal phenotypes by deubiquitinating POLD4 in glioma stem cells.

Fan L, You H, Jiang X, Niu Y, Chen Z, Wang H Cell Mol Life Sci. 2024; 81(1):247.

PMID: 38829550 PMC: 11149539. DOI: 10.1007/s00018-024-05265-5.


References
1.
Johnson D, Ma D, Buckner J, Hammack J . Conditional probability of long-term survival in glioblastoma: a population-based analysis. Cancer. 2012; 118(22):5608-13. DOI: 10.1002/cncr.27590. View

2.
Sahm F, Capper D, Jeibmann A, Habel A, Paulus W, Troost D . Addressing diffuse glioma as a systemic brain disease with single-cell analysis. Arch Neurol. 2011; 69(4):523-6. DOI: 10.1001/archneurol.2011.2910. View

3.
Holland E . Progenitor cells and glioma formation. Curr Opin Neurol. 2001; 14(6):683-8. DOI: 10.1097/00019052-200112000-00002. View

4.
van Solinge T, Nieland L, Chiocca E, Broekman M . Advances in local therapy for glioblastoma - taking the fight to the tumour. Nat Rev Neurol. 2022; 18(4):221-236. PMC: 10359969. DOI: 10.1038/s41582-022-00621-0. View

5.
Dolling J, Boreham D, Brown D, Mitchel R, Raaphorst G . Modulation of radiation-induced strand break repair by cisplatin in mammalian cells. Int J Radiat Biol. 1998; 74(1):61-9. DOI: 10.1080/095530098141735. View